Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms
By:
Paid access
|Nov 2019References
- Aster RH. Drug-induced thrombocytopenia. 2nd ed. In: Michelson AD, ed. Platelets. San Diego: Academic Press; 2007: 887–902.
- Kenney B, Stack G. Drug-induced thrombocytopenia. Arch Pathol Lab Med 2009;133:309–14.
- Davoren A, Aster RH. Heparin-induced thrombocytopenia and thrombosis. Am J Hematol 2006;81:36–44.
- Cuker A, Cines DB. How I treat heparin-induced thrombocytopenia. Blood 2012;119:2209–18.
- Warkentin TE. How I diagnose and manage HIT. Hematology Am Soc Hematol Educ Program 2011;2011:143–9.
- Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580–7.
- Visentin GP, Liu CY. Drug-induced thrombocytopenia. Hematol Oncol Clin North Am 2007;21:685–96, vi.
- van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf 2004;27:1243–52.
- Kaufman DW, Kelly JP, Johannes CB, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993;82:2714–18.
- Tcheng JE, Kereiakes DJ, Lincoff AM, et al. Abciximab readministration: results of the ReoPro Readministration Registry. Circulation 2001;104:870–5.
- Reese JA, Li X, Hauben M, et al. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood 2010;116:2127–33.
- Reese JA, Nguyen LP, Buchanan GR, et al. Drug-induced thrombocytopenia in children. Pediatr Blood Cancer 2013;60: 1975–81.
- Arnold DM, Kukaswadia S, Nazi I, et al. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost 2013;11:169–76.
- Garbe E, Andersohn F, Bronder E, et al. Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 2011;68:821–32.
- Azuno Y, Yaga K, Sasayama T, Kimoto K. Thrombocytopenia induced by Jui, a traditional Chinese herbal medicine. Lancet 1999;354:304–5.
- Ohmori T, Nishii K, Hagihara A, Takeda M, Sekido K. Acute thrombocytopenia induced by jui, a traditional herbal medicine. J Thromb Haemost 2004;2:1479–80.
- Royer DJ, George JN, Terrell DR. Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol 2010;84:421–9.
- Lavy R. Thrombocytopenic purpura due to Lupinus termis bean. J Allergy 1964;35:386–9.
- Arnold J, Ouwehand WH, Smith GA, Cohen H. A young woman with petechiae. Lancet 1998;352:618.
- Achterbergh R, Vermeer HJ, Curtis BR, et al. Thrombocytopenia in a nutshell. Lancet 2012;379:776.
- Davies JK, Ahktar N, Ranasinge E. A juicy problem. Lancet 2001;358:2126.
- Belkin GA. Cocktail purpura: an unusual case of quinine sensitivity. Ann Intern Med 1967;66:583–6.
- Christie DJ, Walker RH, Kolins MD, Wilner FM, Aster RH. Quinine-induced thrombocytopenia following intravenous use of heroin. Arch Intern Med 1983;143:1174–5.
- Taetle R, Browning S. Thrombocytopenia associated with intravenous heroin abuse. West J Med 1979;131:62–4.
- Czuchlewski DR, Brackney M, Ewers C, et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 2010;133:466–72.
- Jardim DL, Rodrigues CA, Novis YA, Rocha VG, Hoff PM. Oxaliplatin-related thrombocytopenia. Ann Oncol 2012;23:1937–42.
- Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000–2007. Clin Ther 2009;31 Pt 2:2416–32.
- Zeuner A, Signore M, Martinetti D, Bartucci M, Peschle C, De Maria R. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res 2007;67:4767–73.
- Curtis BR, Kaliszewski J, Marques MB, et al. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol 2006;81:193–8.
- Bozec L, Bierling P, Fromont P, et al. Irinotecan-induced immune thrombocytopenia. Ann Oncol 1998;9:453–5.
- Fontão-Wendel R, Hoff PM, Lazar A, et al. Immune-mediated pancytopenia induced by oxaliplatin: a case report. Transfusion 2010;50:1453–9.
- Taleghani BM, Meyer O, Fontana S, et al. Oxaliplatin-induced immune pancytopenia. Transfusion 2005;45:704–8.
- Bautista MA, Stevens WT, Chen CS, Curtis BR, Aster RH, Hsueh CT. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. J Hematol Oncol 2010;3:12.
- James E, Podoltsev N, Salehi E, Curtis BR, Saif MW. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect? Clin Colorectal Cancer 2009;8:220–4.
- Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Jr. Clinical guideline update on “Immune thrombocytopenia: an evidence based practice guideline developed by the American Society of Hematology.” Blood 2011;117:4190-4207.
- McFarland JG. Post-transfusion purpura. In: Popovsky MA, ed. Transfusion Reactions. 4th ed. Bethesda, MD: AABB Press;2009,263-82.
- Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol 2008;142:348–60.
- Reddy JC, Shuman MA, Aster RH. Quinine/quinidine-induced thrombocytopenia: a great imitator. Arch Intern Med 2004;164:218–20.
- George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998;129:886–90.
- George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program 2009:153–8.
- Pedersen-Bjergaard U, Andersen M, Hansen PB. Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol 1997;52:183–9.
- Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/ IIIa complex. Blood 1994;84:176–83.
- Visentin GP, Newman PJ, Aster RH. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood 1991;77:2668–76.
- Visentin GP, Wolfmeyer K, Newman PJ, Aster RH. Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 1990;30: 694–700.
- Drug-induced immune thrombocytopenia: results of the testing for drug-dependent platelet-reactive antibodies by the BloodCenter of Wisconsin. Available at: http://ouhsc.edu/ platelets/InternetPostingLab2_18_11Frames.htm. Accessed November 18, 2013.
- Kiefel V, Santoso S, Schmidt S, Salama A, Mueller-Eckhardt C. Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia. Transfusion 1987;27:262–5.
- Bougie DW, Benito AI, Sanchez-Abarca LI, Torres R, Birenbaum J, Aster RH. Acute thrombocytopenia caused by sensitivity to the glucuronide conjugate of acetaminophen. Blood 2007;109:3608–9.
- Pfueller SL, Bilston RA, Logan D, Gibson JM, Firkin BG. Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine- and quinidine-induced thrombocytopenia: involvement of glycoproteins Ib, IIb, IIIa, and IX. Blood 1988;72:1155–62.
- Peterson JA, Nelson TN, Kanack AJ, Aster RH. Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA. Blood 2008;111:1234–9.
- Peterson JA, Nyree CE, Newman PJ, Aster RH. A site involving the “hybrid” and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia. Blood 2003;101:937–42.
- Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycin-induced immune thrombocytopenia. N Engl J Med 2007;356: 904–10.
- Burgess JK, Lopez JA, Berndt MC, Dawes I, Chesterman CN, Chong BH. Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: characterization of the epitopes. Blood 1998;92:2366–73.
- Gentilini G, Curtis BR, Aster RH. An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies. Blood 1998;92:2359–65.
- Kroll H, Sun QH, Santoso S. Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. Blood 2000;96:1409–14.
- Christie DJ, Mullen PC, Aster RH. Quinine- and quinidine platelet antibodies can react with GPIIb/IIIa. Br J Haematol 1987;67:213–19.
- Bougie DW, Nayak D, Boylan B, Newman PJ, Aster RH. Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia. Blood 2010;116:3033–8.
- Aster RH. Drug-induced immune cytopenias. Toxicology 2005;209:149–53.
- Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 2009;7:911–8.
- Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies. Blood 2006;108:922–7.
- Aster RH, Curtis BR, Bougie DW. Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors. Semin Thromb Hemost 2004;30:569–77.
- Ries CA, Rosenbaum TJ, Garratty G, Petz LD, Fudenberg HH. Penicillin-induced immune hemolytic anemia. Occurrence of massive intravascular hemolysis. JAMA 1975;233:432–5.
- Aster RH. Can drugs cause autoimmune thrombocytopenic purpura? Semin Hematol 2000;37:229–38.
- Bougie DW, Wilker PR, Wuitschick ED, et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood 2002;100:2071–6.
- Bednar B, Cook JJ, Holahan MA, et al. Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa. Blood 1999;94: 587–99.
- Curtis BR, Swyers J, Divgi A, McFarland JG, Aster RH. Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets. Blood 2002;99:2054–9.
- Curtis BR, Divgi A, Garritty M, Aster RH. Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2004;2:985–92.
- Christopoulos C. Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa. Clin Exp Immunol 1994;98:6–11.
- Christie DJ, Mullen PC, Aster RH. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 1985;75: 310–14.
- Asvadi P, Ahmadi Z, Chong BH. Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies. Blood 2003;102: 1670–7.
- Bougie DW, Birenbaum J, Rasmussen M, Poncz M, Aster RH. Quinine-dependent, platelet-reactive monoclonals mimic antibodies found in patients with quinine-induced immune thrombocytopenia. Blood 2009;113:1105–11.
DOI: https://doi.org/10.21307/immunohematology-2019-099 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 55 - 65
Published on: Nov 6, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2019 B.R. Curtis, published by American National Red Cross
This work is licensed under the Creative Commons License.